ARCALIS, Inc.
PrivateLast Round
Strategic
Nov 14, 2024
Total Funding Raised
$274.11M
Company Overview
ARCALIS, Inc. is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) specializing in mRNA vaccines and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Drug Discovery, Smart Manufacturing, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARCALIS, Inc. Comparables
Compare ARCALIS, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RiboPro | 84% | |
| Vernal Biosciences | 82% | |
| Anemocyte | 80% | |
ARCALIS, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 14, 2024 | ||||
| Debt | Jan 31, 2024 | ||||
| Grant | Oct 4, 2023 | ||||
| Debt | Oct 31, 2022 |
ARCALIS, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sumitomo Mitsui Trust Bank | Debt |
| Joyo Bank, Ltd. | Debt |
| Ministry of Economy, Trade and Industry | Grant |
| Aozora Bank | Debt |
| Sumitomo Mitsui Banking Corporation | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 128% MoM, reaching 5.8K.
- Oct 29, 2024
Monthly visitors increased 188% MoM, reaching 7.5K.
ARCALIS, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ARCALIS, Inc.'s valuation, stock price, and market status.